Trials on trial: 'short-term pain' needed for broken clinical enterprise
This article was originally published in Scrip
Executive Summary
A comprehensive redesign of the entire clinical trial enterprise must be considered if we are to tackle the deficit of evidence underpinning clinical practice guidelines, say researchers from Duke University in JAMA.